Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

And breathe…

…or, why there is no ‘fast track’  to communications excellence

- PMLiVE

Humanisation

The key to delivering communications excellence

- PMLiVE

Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio

Germany and the UK will be the first to receive the skin cancer treatment

- PMLiVE

Intercept hit hard as FDA issues Ocaliva safety notice

The PBC treatment has been linked to 19 deaths and 11 cases of liver damage

- PMLiVE

Translation company Conversis appoints Jamie Newall as CEO

He will also sit on the UK firm's board

- PMLiVE

Former GSK CEO joins Synthego’s advisory board

Sir Andrew Witty will expand the team’s bioinformatics expertise

- PMLiVE

Attracting doctors to low-demand specialties

A role for industry?

- PMLiVE

Signal strength

Communications that connect

- PMLiVE

Novartis gets EU nod for leukaemia drug Rydapt

The FLT3 inhibitor adds to its US approval in AML

- PMLiVE

Alnylam takes off on APOLLO trial results

Provides first late-stage evidence on the biotech's gene-silencing platform

Teva’s Mark Salyer joins Amarin

Takes up newly-created chief commercial officer role

- PMLiVE

FDA approves Medtronic’s tablet-controlled pain device

The Intellis system can be programmed via a Samsung's Galaxy S2

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links